MOACM
WST icon

Mutual of America Capital Management’s West Pharmaceutical WST Stock Holding History

Mutual of America Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.92M Sell
7,674
-70
-0.9% -$17.4K 0.02% 780
2025
Q4 		$2.13M Sell
7,744
-69
-0.9% -$18.9K 0.02% 787
2025
Q3 		$2.05M Sell
7,813
-442
-5% -$107K 0.02% 812
2025
Q2 		$1.81M Sell
8,255
-187
-2% -$40K 0.02% 848
2025
Q1 		$1.89M Sell
8,442
-252
-3% -$69.5K 0.02% 850
2024
Q4 		$2.85M Sell
8,694
-260
-3% -$81.8K 0.03% 724
2024
Q3 		$2.69M Sell
8,954
-253
-3% -$77.5K 0.03% 773
2024
Q2 		$3.03M Sell
9,207
-517
-5% -$183K 0.03% 712
2024
Q1 		$3.85M Sell
9,724
-198
-2% -$73.2K 0.04% 608
2023
Q4 		$3.49M Sell
9,922
-437
-4% -$155K 0.04% 639
2023
Q3 		$3.89M Sell
10,359
-339
-3% -$131K 0.05% 542
2023
Q2 		$4.09M Buy
10,698
+82
+0.8% +$29.3K 0.05% 574
2023
Q1 		$3.68M Buy
10,616
+18
+0.2% +$5.26K 0.04% 633
2022
Q4 		$2.49M Buy
10,598
+324
+3% +$76.8K 0.03% 803
2022
Q3 		$2.53M Buy
10,274
+152
+2% +$46.3K 0.03% 739
2022
Q2 		$3.06M Buy
10,122
+218
+2% +$70.9K 0.04% 683
2022
Q1 		$4.07M Buy
9,904
+104
+1% +$40.7K 0.04% 652
2021
Q4 		$4.6M Buy
9,800
+79
+0.8% +$34K 0.05% 613
2021
Q3 		$4.13M Buy
9,721
+76
+0.8% +$32K 0.04% 634
2021
Q2 		$3.46M Buy
9,645
+73
+0.8% +$24.1K 0.03% 734
2021
Q1 		$2.7M Buy
9,572
+329
+4% +$94.2K 0.03% 836
2020
Q4 		$2.62M Sell
9,243
-381
-4% -$107K 0.03% 797
2020
Q3 		$2.65M Sell
9,624
-439
-4% -$116K 0.04% 680
2020
Q2 		$2.29M Sell
10,063
-58,798
-85% -$11.6M 0.03% 764
2020
Q1 		$10.5M Buy
68,861
+1,810
+3% +$279K 0.18% 97
2019
Q4 		$10.1M Buy
67,051
+1,163
+2% +$169K 0.13% 148
2019
Q3 		$9.34M Buy
65,888
+840
+1% +$116K 0.13% 154
2019
Q2 		$8.14M Sell
65,048
-521
-0.8% -$61.5K 0.12% 182
2019
Q1 		$7.23M Sell
65,569
-78
-0.1% -$8.11K 0.11% 220
2018
Q4 		$6.43M Buy
65,647
+3,648
+6% +$396K 0.11% 225
2018
Q3 		$7.66M Sell
61,999
-1,510
-2% -$169K 0.11% 217
2018
Q2 		$6.31M Buy
63,509
+3,092
+5% +$285K 0.09% 271
2018
Q1 		$5.33M Sell
60,417
-522
-0.9% -$48.8K 0.08% 340
2017
Q4 		$6.01M Sell
60,939
-706
-1% -$69.2K 0.09% 307
2017
Q3 		$5.93M Buy
61,645
+24
+0% +$2.17K 0.1% 278
2017
Q2 		$5.82M Buy
61,621
+3,973
+7% +$365K 0.1% 261
2017
Q1 		$4.71M Buy
57,648
+1,189
+2% +$99.4K 0.08% 358
2016
Q4 		$4.79M Sell
56,459
-13,359
-19% -$1.05M 0.09% 313
2016
Q3 		$5.2M Buy
69,818
+896
+1% +$71.1K 0.1% 253
2016
Q2 		$5.23M Sell
68,922
-19,979
-22% -$1.45M 0.11% 225
2016
Q1 		$6.16M Buy
88,901
+41,053
+86% +$2.47M 0.14% 154
2015
Q4 		$2.88M Sell
47,848
-163
-0.3% -$9.81K 0.06% 462
2015
Q3 		$2.6M Buy
+48,011
New +$2.8M 0.06% 498

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mutual of America Capital Management's WST Position: Q1 2026 in Review

Mutual of America Capital Management reduced its West Pharmaceutical (WST) stake by 0.9% in Q1 2026, selling an estimated $17.4K and leaving 7,674 shares worth $1.92M. The position accounts for 0.02% of the portfolio, ranked #780.

Mutual of America Capital Management first reported a position in WST in Q3 2015 and has held it in 43 quarters since. The position peaked at $10.5M in Q1 2020. 754 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Mutual of America Capital Management held 7,674 shares of West Pharmaceutical worth $1.92M as of Q1 2026.
  • Mutual of America Capital Management sold 70 West Pharmaceutical shares in Q1 2026, an estimated $17.4K.
  • West Pharmaceutical made up 0.02% of Mutual of America Capital Management's portfolio in Q1 2026, its #780 holding.
  • Mutual of America Capital Management first reported a position in West Pharmaceutical in Q3 2015 and has held it in 43 quarters since.
  • Mutual of America Capital Management's West Pharmaceutical position peaked at $10.5M in Q1 2020.
  • 754 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Mutual of America Capital Management's 13F filing for Q1 2026, filed 7 May 2026.